Pseudotumor Cerebri Associated with Initiation of Levothyroxine Therapy for Juvenile Hypothyroidism

Cornelis Van Dop, Felix A. Conte, Thomas K. Koch, Susan J. Clark, Suzanne L. Wilson-Davis, Melvin M. Grumbach

Research output: Contribution to journalArticle

57 Scopus citations

Abstract

Pseudotumor CEREBRI (benign intracranial hypertension), a syndrome characterized by increased intracranial pressure without focal neurologic dysfunction, occurs in association with a variety of endocrine and metabolic disorders. Thyroid disorders have not been described in association with pseudotumor cerebri except in two reports of hyperthyroidism1,2 and two reports on patients receiving thyroxine therapy for hypothyroidism.3,4 In fact, when thyroxine has been used in appropriate doses as replacement therapy for hypothyroidism, it has been associated with very few side effects. We now describe two children in whom pseudotumor cerebri developed shortly after the initiation of thyroid therapy for hypothyroidism due to autoimmune.

Original languageEnglish (US)
Pages (from-to)1076-1080
Number of pages5
JournalNew England Journal of Medicine
Volume308
Issue number18
DOIs
StatePublished - May 5 1983

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Van Dop, C., Conte, F. A., Koch, T. K., Clark, S. J., Wilson-Davis, S. L., & Grumbach, M. M. (1983). Pseudotumor Cerebri Associated with Initiation of Levothyroxine Therapy for Juvenile Hypothyroidism. New England Journal of Medicine, 308(18), 1076-1080. https://doi.org/10.1056/NEJM198305053081807